References
- Bertino , J. R. , Sawicki , W. L. , Moroson , B. A. , Cashmore , A. R. and Elslager , E. F. 1979 . 2,3-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino) methyl]quinazoline (TMQ), a Potent Non-Classical Folate Antagonist Inhibitor-I . Biochem Pharmacol. , 28 : 1983
- Diddens , H. , Niethammer , D. and Jackson , R. C. 1983 . Patterns of Cross-Resistance to the Antifolate Drugs Trimetrexate, Metoprine, Homofolate, and CB3717 in Human Lymphoma and Osteosarcoma Cells Resistant to Methotrexate . Cancer Res. , 43 : 5286
- Weir , E. C. , Cashmore , A. R. , Dreyer , R. N. , Graham , M. L. , Hsiao , N. , Moroson , B. A. , Sawicki , W. L. and Bertino , J. R. 1982 . Pharmacology and Toxicity of a Potent “Nonclassical” 2,4-Diamino Quinazoline Folate Antagonist, Trimetrexate, in Normal Dogs . Cancer Res. , 42 : 1696
- Heusner , J. J. and McCormack , J. J. 1981 . Enzymatic Assays for 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino) methyl] quinazoline, a Promising New “Nonclassical” Antifolate . J. Pharm. Sci. , 70 : 827
- Heusner , J. J. 1983 . Ph.D. thesis University of Vermont .